fda stops tirzepatide approves to treat sleep apnea FDA ban on compounded tirzepatide:

GLP-1 (glucagon-like peptide 1) is a hormone similar to glucagon

Finally, the primary outcome is a surrogate measured during a short follow-up period. They are also honest: We are, therefore, not able to draw conclusions about the longer-term effects of semaglutide in this population. And they conclude that: These findings support future clinical trials to assess the efficacy of semaglutide in reducing the risk of kidney failure and cardiovascular complications in these patients. I would characterize that as a reasonable conclusion given the limitations

Always let your healthcare provider guide any dose changes

Most patients juggle doctors, pharmacies, dose schedules, meal planning, hydration, and sideeffect tracking with adhoc tools like notes and multiple apps

Bottom line: the value pick when price and simplicity matter most

In fact, the pace of regain was nearly four times higher, regardless of how much weight a person initially lost